Literature DB >> 4355632

Epidemiology of respiratory syncytial virus infection in Washington, D.C. 3. Composite analysis of eleven consecutive yearly epidemics.

C D Brandt, H W Kim, J O Arrobio, B C Jeffries, S C Wood, R M Chanock, R H Parrott.   

Abstract

Entities:  

Mesh：

Year:  1973        PMID： 4355632     DOI： 10.1093/oxfordjournals.aje.a121565

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  41 in total

1.  Epidemiology of respiratory syncytial virus infection among paediatric inpatients in northern Taiwan.

Authors:  Y C Huang; T Y Lin; L Y Chang; K S Wong; S C Ning
Journal:  Eur J Pediatr       Date:  2001-09       Impact factor: 3.183

2.  Immunological responses to respiratory syncytial virus infection in infancy.

Authors:  R L Smyth; J N Fletcher; H M Thomas; C A Hart
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

Review 3.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

4.  Evaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees.

Authors:  M L Clements; R B Belshe; J King; F Newman; T U Westblom; E L Tierney; W T London; B R Murphy
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

5.  Comparison of directigen RSV with viral isolation and direct immunofluorescence for the identification of respiratory syncytial virus.

Authors:  J L Waner; N J Whitehurst; S J Todd; H Shalaby; L V Wall
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

6.  Evaluation of the Becton Dickinson Directigen test for respiratory syncytial virus in nasopharyngeal aspirates.

Authors:  T Kok; K Barancek; C J Burrell
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

7.  Potential impact of accelerating the primary dose of rotavirus vaccine in infants.

Authors:  Elizabeth E Halvorson; Timothy R Peters; Beverly M Snively; Katherine A Poehling
Journal:  Vaccine       Date:  2012-02-26       Impact factor: 3.641

8.  Population pharmacokinetics of palivizumab, a humanized anti-respiratory syncytial virus monoclonal antibody, in adults and children.

Authors:  Gabriel J Robbie; Liang Zhao; John Mondick; Genevieve Losonsky; Lorin K Roskos
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

9.  Evaluation of the Abbott TESTPACK RSV enzyme immunoassay for detection of respiratory syncytial virus in nasopharyngeal swab specimens.

Authors:  E M Swierkosz; R Flanders; L Melvin; J D Miller; M W Kline
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

10.  Experimental pneumovirus infections. 2. Hydrocephalus of hamsters and mice due to infection with human respiratory syncytial virus (RS).

Authors:  J Lagacé-Simard; J P Descôteaux; G Lussier
Journal:  Am J Pathol       Date:  1982-04       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.